Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib or Bevacizumab with Cisplatin and Gemcitabine in NPC
NCT01309633Phase 2Completed
- Sponsor
- National University Hospital
- Start
- Sep 2011
- Primary completion
- Mar 2019
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib, bevacizumab in nasopharyngeal carcinoma (NPC), sponsored by National University Hospital. Started Sep 2011; status: completed.
02
Drugs
sunitinibbevacizumab
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT01309633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01309633.